RCE Technologies, the developer of a non-invasive, instant measurement of cardiac proteins was selected as the winner of the annual Health Tech competition at the 2023 American Heart Association (AHA) Scientific Sessions (11–13 November, Philadelphia, USA).
The winning technology focuses on “diagnosing and treating myocardial heart injury in real time to empower [health care professionals] to provide the best patient care,” said Atandra Burman, founder and CEO of RCE Technologies.
Judges selected RCE Technologies as the winner based on validity of the working prototype, scientific rigor and potential impact on patient outcomes.
RCE Technologies will receive membership to the Center for Health Technology & Innovation Innovators’ Network, a consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ Network members also have access to the Association’s digital evidence-based guidelines, clinical recommendations and best-in-class science to support development of digital health care technologies. Members collaborate by building and sharing models for clinical outcome studies, lowering the significant cost of developing those studies independently, among other activities.
The technology was also entered into the Shark Tank Innovation Competition at the 2023 TCT conference (23–26 October, San Francisco, USA).
